|
AIDS Research and Human Retroviruses
Systemic Immune Activation in HIV-1-Exposed Uninfected Vietnamese Intravascular Drug Users
To cite this article:
Hung K. Tran, Loïc Chartier, Lien X. Troung, Ngai N. Nguyen, Arnaud Fontanet, François E. Barré-Sinoussi, Gianfranco Pancino, Daniel Scott-Algara.
AIDS Research and Human Retroviruses.
March 2006,
22(3): 255-261.
doi:10.1089/aid.2006.22.255.
Hung K. Tran Institut Pasteur, Ho Chi Minh City, Vietnam. Loïc Chartier Hôpital Binh Trieu, Ho Chi Minh City, Vietnam. Lien X. Troung Institut Pasteur, Ho Chi Minh City, Vietnam. Ngai N. Nguyen Unité de Recherche et d'Expertise Epidémiologie des Maladies Emergentes, Institut Pasteur, Paris, France. Arnaud Fontanet Hôpital Binh Trieu, Ho Chi Minh City, Vietnam. François E. Barré-Sinoussi Unité de Régulations des Infections Rétrovirales, Institut Pasteur, Paris, France. Gianfranco Pancino Unité de Régulations des Infections Rétrovirales, Institut Pasteur, Paris, France. Daniel Scott-Algara Unité de Régulations des Infections Rétrovirales, Institut Pasteur, Paris, France. To assess immunological parameters, including markers of immune activation, in highly HIV-1-exposed uninfected (EU) Vietnamese intravascular drug users (IDUs) in comparison with HIV-1-infected IDUs and HIVunexposed controls, we determined peripheral lymphocyte phenotypes in fresh whole blood samples from 32 EU IDUs, 28 HIV+ IDUs, and 26 blood donors. We found higher levels of activation markers (CD38, HLADR) on CD4+ and CD8+ T cells, lower percentages of naive CD4+ and CD8+ T cells, higher percentages of CD8+ T cells and of CD8+ T cells expressing CD25, and lower levels of CXCR4+CD4+ T cells in EU IDUs than in unexposed controls. Despite several differences in CD4+ and CD8+ T cell subset phenotypes, both EU and HIV+ IDUs exhibited a pattern of peripheral immune activation. Lymphocyte activation in EU IDUs may reflect immune stimulation driven by viral infections other than HIV-1 and/or allogeneic stimulation associated with needle sharing. Our results suggest that immune activation does not necessarily favor HIV-1 transmission, but, on the contrary, may alter the susceptibility of EUs to HIV-1 infection and contribute to their resistance.  This paper was cited by:The ‘immunologic advantage’ of HIV-exposed seronegative individuals Masaaki Miyazawa, Lucia Lopalco, Francesco Mazzotta, Sergio Lo Caputo, Francisco Veas, Mario Clerici AIDS. Feb 2009, Vol. 23, No. 2: 161-175 CrossRef Impaired Viral Entry Cannot Explain Reduced CD4+ T Cell Susceptibility to HIV Type 1 in Certain Highly Exposed Individuals Emily C. Speelmon, Devon Livingston-Rosanoff, Anthony L. Desbien, Jean Lee, W. David Wick, Florian Hladik, M. Juliana McElrath AIDS Research and Human Retroviruses. Nov 2008, Vol. 24, No. 11: 1415-1427 Abstract | Full Text PDF | Reprints & Permissions
|
|